Vaccines And ImmunizationVaccine Topic

Debate about using an unmuted oncogenic viral protein as a vaccine antigen

April 4, 2026Wafik S. El-Deiry, MD, PhD, FACP

Wafik S. El-Deiry reframes a controversy as a general vaccine design question about whether an unmuted oncogenic viral protein should be used as an antigen, citing a Google AI response and implying confusion and backlash around the original framing.

For the critics who misunderstood and attacked my question let me rephrase it more generally “is it a good idea to use an unmuted oncogenic viral protein as an antigen to vaccinate against infection by that virus?”
Google AI response to rephrased question: “Using an unmutated
Wafik S. El-Deiry, MD, PhD, FACP
vaccine safetyantigen design

See what experts are saying right now

This finding is one of many signals tracked across Healthcare. The live feed updates every few hours with new expert voices, debates, and emerging ideas.

← Back to Healthcare